官方:新型冠状病毒感染的肺炎简称“新冠肺炎”,英文简称“NCP”

2020-02-08 佚名 医谷

今日,国家卫健委医政医管局发布《国家卫生健康委关于新型冠状病毒肺炎暂命名事宜的通知》,根据通知,“新型冠状病毒感染的肺炎”暂命名为“新型冠状病毒肺炎”。

今日,国家卫健委医政医管局发布《国家卫生健康委关于新型冠状病毒肺炎暂命名事宜的通知》,根据通知,“新型冠状病毒感染的肺炎”暂命名为“新型冠状病毒肺炎”,简称“新冠肺炎”;英文名称为“Novel Coronavirus Pneumonia”,简称“NCP”。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1651317, encodeId=be53165131e86, content=<a href='/topic/show?id=d07d5818eda' target=_blank style='color:#2F92EE;'>#新型冠状病毒感染的肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58187, encryptionId=d07d5818eda, topicName=新型冠状病毒感染的肺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d2524156628, createdName=hb2016ye, createdTime=Sun Oct 11 05:12:00 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636181, encodeId=2c6316361819a, content=<a href='/topic/show?id=26eb3092232' target=_blank style='color:#2F92EE;'>#冠状病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30922, encryptionId=26eb3092232, topicName=冠状病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53a422597656, createdName=zjshifan_98647313, createdTime=Tue Jul 07 14:12:00 CST 2020, time=2020-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1840205, encodeId=344f18402057f, content=<a href='/topic/show?id=5e4158186f7' target=_blank style='color:#2F92EE;'>#新型冠状病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58186, encryptionId=5e4158186f7, topicName=新型冠状病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=shuangle, createdTime=Fri Aug 21 02:12:00 CST 2020, time=2020-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1027095, encodeId=2f5d102e09593, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Sat Feb 08 20:12:00 CST 2020, time=2020-02-08, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1651317, encodeId=be53165131e86, content=<a href='/topic/show?id=d07d5818eda' target=_blank style='color:#2F92EE;'>#新型冠状病毒感染的肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58187, encryptionId=d07d5818eda, topicName=新型冠状病毒感染的肺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d2524156628, createdName=hb2016ye, createdTime=Sun Oct 11 05:12:00 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636181, encodeId=2c6316361819a, content=<a href='/topic/show?id=26eb3092232' target=_blank style='color:#2F92EE;'>#冠状病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30922, encryptionId=26eb3092232, topicName=冠状病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53a422597656, createdName=zjshifan_98647313, createdTime=Tue Jul 07 14:12:00 CST 2020, time=2020-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1840205, encodeId=344f18402057f, content=<a href='/topic/show?id=5e4158186f7' target=_blank style='color:#2F92EE;'>#新型冠状病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58186, encryptionId=5e4158186f7, topicName=新型冠状病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=shuangle, createdTime=Fri Aug 21 02:12:00 CST 2020, time=2020-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1027095, encodeId=2f5d102e09593, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Sat Feb 08 20:12:00 CST 2020, time=2020-02-08, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1651317, encodeId=be53165131e86, content=<a href='/topic/show?id=d07d5818eda' target=_blank style='color:#2F92EE;'>#新型冠状病毒感染的肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58187, encryptionId=d07d5818eda, topicName=新型冠状病毒感染的肺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d2524156628, createdName=hb2016ye, createdTime=Sun Oct 11 05:12:00 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636181, encodeId=2c6316361819a, content=<a href='/topic/show?id=26eb3092232' target=_blank style='color:#2F92EE;'>#冠状病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30922, encryptionId=26eb3092232, topicName=冠状病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53a422597656, createdName=zjshifan_98647313, createdTime=Tue Jul 07 14:12:00 CST 2020, time=2020-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1840205, encodeId=344f18402057f, content=<a href='/topic/show?id=5e4158186f7' target=_blank style='color:#2F92EE;'>#新型冠状病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58186, encryptionId=5e4158186f7, topicName=新型冠状病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=shuangle, createdTime=Fri Aug 21 02:12:00 CST 2020, time=2020-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1027095, encodeId=2f5d102e09593, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Sat Feb 08 20:12:00 CST 2020, time=2020-02-08, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1651317, encodeId=be53165131e86, content=<a href='/topic/show?id=d07d5818eda' target=_blank style='color:#2F92EE;'>#新型冠状病毒感染的肺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58187, encryptionId=d07d5818eda, topicName=新型冠状病毒感染的肺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d2524156628, createdName=hb2016ye, createdTime=Sun Oct 11 05:12:00 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636181, encodeId=2c6316361819a, content=<a href='/topic/show?id=26eb3092232' target=_blank style='color:#2F92EE;'>#冠状病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30922, encryptionId=26eb3092232, topicName=冠状病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53a422597656, createdName=zjshifan_98647313, createdTime=Tue Jul 07 14:12:00 CST 2020, time=2020-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1840205, encodeId=344f18402057f, content=<a href='/topic/show?id=5e4158186f7' target=_blank style='color:#2F92EE;'>#新型冠状病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58186, encryptionId=5e4158186f7, topicName=新型冠状病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=shuangle, createdTime=Fri Aug 21 02:12:00 CST 2020, time=2020-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1027095, encodeId=2f5d102e09593, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Sat Feb 08 20:12:00 CST 2020, time=2020-02-08, status=1, ipAttribution=)]
    2020-02-08 公卫新人

    新冠肺炎,疫情何时才能消失

    0

相关资讯

日本载3711人游轮新增41人确诊新型冠状病毒肺炎 其中21人为日本籍

据共同社、NHK报道,日本“钻石公主”号游轮上发生新型冠状病毒集体感染,厚生劳动省对乘客和船员约3711人开展病毒检测。2月7日,厚生劳动省宣布,新查明结果的171人中,41人感染新型冠状病毒,感染人数总计已达61人。不过,日本厚生劳动相加藤胜信称,新确认感染新型冠状病毒的41人中没有重症患者。此外,厚劳省还发布新确认感染新型冠状病毒的41人国籍,具体为21名日本人,8名美国人、5名澳大利亚人、5

判断病情轻重有简单指标!武汉同济医院学者称,近二成患者有呼吸困难

武汉同济医院呼吸与危重症医学科周灵和刘辉国在《中华结核和呼吸杂志》上发表专题笔谈,指出自发病到出现呼吸困难的时间不足3天者的患者,提示病情进展迅速,通常预示着预后不良。作者指出,患者从出现症状至就诊的时间一般为4~8天,中位时间为7天。研究发现,患者从出现症状至就诊的时间,可作为患者病情轻重的评估标准。病情重、进展快的患者,时间较短;而病情轻、进展较为缓慢的患者,初诊时间则较长。根据新型冠状病毒感

高血压患者感染新冠肺炎后如何进行降压药物治疗?听专家这样说......

截至2月6日22时,全国确诊的新型冠状病毒病例达到了28135例,死亡564例。老年人因免疫功能和抵抗能力相对较弱,是这次新型冠状病毒感染的易感人群和高危易发人群,在本次疫情的危重症人群中占比较高。“全国的病死率在疫情初期是2.3%,现在是2.1%,可以说略有下降。其中,死亡患者以男性为主,占三分之二,女性占三分之一,且以高龄为主,80%以上都是60岁以上的老年人,75%以上是有一种或一种以上的基

CT结果列为湖北诊断标准!第五版新冠病毒肺炎诊疗方案15大变化

在疫情一线工作的医生发现,一些患者核酸检测结果为阴性,病情却在持续发展,且家人也出现感染。除了核酸检测,不少专家提出,CT影像结果也应纳入新冠肺炎的筛查标准,这是否可行?专家的呼吁已获得决策层面的回应。就在2月5日下午,国家卫健委发布《新型冠状病毒感染的肺炎的诊疗方案(试行第五版)》,规定将CT影像结果作为临床诊断病例的诊断标准,但这一规定只限于湖北省内。《新型冠状病毒感染的肺炎诊疗方案(试行

瑞德西韦用于严重新冠肺炎的临床试验解析

2月5日下午,北京中日友好医院王辰、曹彬团队在武汉市金银潭医院宣布启动瑞德西韦(remdesivir)治疗2019新型冠状病毒感染研究。目前在Clinicaltrials上能查询到remdesivir针对轻中度新冠肺炎和重度新冠肺炎的两个研究。重度新冠肺炎研究试验的名称:A Phase 3 Randomized, Double-blind, Placebo-controlled, Multic

瑞德西韦治疗新冠肺炎的临床试验在武汉启动!

在科技部、国家卫健委、国家药监局等多部门支持下,抗病毒药物瑞德西韦(remdesivir)已完成临床试验的注册审批工作,第一批病例入组工作也已就位。首批新型冠状病毒感染的肺炎重症患者2月6日将接受用药。2月5日,瑞德西韦临床试验项目负责人、中日友好医院副院长曹彬教授讲解项目内容(新华社记者 程敏 摄)瑞德西韦临床试验项目负责人、中日友好医院副院长曹彬教授介绍,瑞德西韦是美国吉利德公司的在研药物,在